- Home
- SGC vs JUNS Comparison
SGC vs JUNS Comparison
Compare SGC & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGC
- JUNS
- Stock Information
- Founded
- SGC 1920
- JUNS 2015
- Country
- SGC United States
- JUNS United States
- Employees
- SGC N/A
- JUNS N/A
- Industry
- SGC Apparel
- JUNS
- Sector
- SGC Consumer Discretionary
- JUNS
- Exchange
- SGC Nasdaq
- JUNS NYSE
- Market Cap
- SGC 155.7M
- JUNS 20.5M
- IPO Year
- SGC N/A
- JUNS 2024
- Fundamental
- Price
- SGC $11.10
- JUNS $2.37
- Analyst Decision
- SGC Strong Buy
- JUNS
- Analyst Count
- SGC 3
- JUNS 0
- Target Price
- SGC $17.00
- JUNS N/A
- AVG Volume (30 Days)
- SGC 51.9K
- JUNS 723.2K
- Earning Date
- SGC 08-05-2025
- JUNS 08-11-2025
- Dividend Yield
- SGC 5.04%
- JUNS N/A
- EPS Growth
- SGC N/A
- JUNS N/A
- EPS
- SGC 0.45
- JUNS N/A
- Revenue
- SGC $563,931,000.00
- JUNS N/A
- Revenue This Year
- SGC N/A
- JUNS N/A
- Revenue Next Year
- SGC $4.31
- JUNS N/A
- P/E Ratio
- SGC $24.75
- JUNS N/A
- Revenue Growth
- SGC 2.28
- JUNS N/A
- 52 Week Low
- SGC $9.11
- JUNS $0.51
- 52 Week High
- SGC $20.75
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- SGC 63.34
- JUNS N/A
- Support Level
- SGC $10.77
- JUNS N/A
- Resistance Level
- SGC $11.28
- JUNS N/A
- Average True Range (ATR)
- SGC 0.37
- JUNS 0.00
- MACD
- SGC 0.08
- JUNS 0.00
- Stochastic Oscillator
- SGC 88.72
- JUNS 0.00
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.